BD launches next generation prefillable vaccine syringe designed for reliability & efficiency

BD EffivaxTM Glass Prefillable Syringe features enhanced technology that builds on company’s decades of expertise in the prefillable syringe market and supports customers’ manufacturing needs.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.

The new BD Effivax^TM Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.